Hello, Fool! | Login | Signup | My Fool
Aug 30, 2008 12:08 AM ET | Site Changes | Help
A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
View All Commentary (RGEN)
Recs
cronsmith (60.08) Submitted: 6/01/08 10:25 PM : Start Price: $5.73 RGEN Score: 1.61
Undervalued. Good Fundamentals.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK